Table 1. Sample information for urinary EV RNA-seq analysis.
| ID | Disease group | Age | Sex | Stage | Grade | Cytology | Comment |
|---|---|---|---|---|---|---|---|
| RS01 | Healthy control | 38 | M | - | - | n.d.a | |
| RS02 | Healthy control | 65 | M | - | - | n.d. | |
| RS03 | Healthy control | 65 | F | - | - | n.d. | |
| RS04 | Disease control | 43 | M | - | - | n.d. | Atypical epithelium, reddened |
| RS05 | No residual tumor | 79 | M | - | - | Negative | Previous bladder cancer: pTa, pTis, G1 |
| RS06 | No residual tumor | 57 | F | - | - | Negative | Previous bladder cancer: stage unknown, G1/G2 |
| RS07 | Bladder cancer | 81 | F | pTa | G2 | Suspicious | Six recurrences |
| RS08 | Bladder cancer | 73 | M | pTa | G2 | Negative | Five recurrences |
| RS09 | Bladder cancer | 81 | M | pTa | G2 | Negative | First manifestation |
| RS10 | Bladder cancer | 64 | M | pT4a | G3 | Positive | First manifestation, cystectomy |
| RS11 | Renal pelvis cancer | 65 | F | pT2 | G3 | Negative | First manifestation, nephrectomy |
| RS12 | Renal pelvis cancer | 81 | F | pT3 | G3 | Negative | First manifestation, nephrectomy |
Sample information used for urinary EV RNA-seq analysis is shown. Disease group, cancer stages and grades were determined as described in the Materials and Methods. anot determined.